FTC sues significant pharmacy advantage managers around insulin price ranges The company brought action against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing price of lifestyle-saving insulin prescription drugs. Wherever are all the nurses? Hospitals, advocates disagree on crisis Hospitals and https://knoxyvrie.bloggerswise.com/37490440/about-healthcare-news